FLUDEOXYGLUCOSE (18F) INJECTION

Product Overview

About FLUDEOXYGLUCOSE (18F) INJECTION

FLUDEOXYGLUCOSE (18F) INJECTION is a radiopharmaceutical agent used in positron emission tomography (PET) imaging for the assessment of glucose metabolism in the brain. It is a fluorine-18 labeled analog of glucose, designed to accumulate in areas of high glucose uptake, such as tumors and areas of inflammation.

Key Benefits & Uses

• Assessment of glucose metabolism in the brain for the diagnosis and monitoring of brain tumors, such as gliomas and meningiomas.
• Imaging of areas of inflammation and infection in the brain, such as abscesses and encephalitis.
• Assessment of glucose metabolism in the brain for the diagnosis and monitoring of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Active Ingredient & Action

FLUDEOXYGLUCOSE 18F is a fluorine-18 labeled analog of glucose that is taken up by cells through the glucose transporter. It is then phosphorylated by hexokinase to form FDG-6-phosphate, which is trapped within the cell and accumulates in areas of high glucose uptake. The accumulation of FLUDEOXYGLUCOSE 18F in tumors and areas of inflammation allows for the visualization of these areas through PET imaging.

Important Notes

FLUDEOXYGLUCOSE (18F) INJECTION should only be used under the guidance of a qualified nuclear medicine physician. It is essential to follow proper dosing and administration guidelines to ensure safe and effective use. Patients should be advised to inform their healthcare provider of any medical conditions or allergies before receiving this medication.